Events & Presentations

Investors

Events & Presentations

Upcoming Events
More events are coming soon.
Archived Events
Date Event Details
Nov 28, 2017 9:30 AM EST
29th Annual Piper Jaffray Healthcare Conference
Nov 13 - Nov 15, 2017 12:00 AM EST
BIT's 8th World Gene Convention-2017
Macau, China
Oct 23, 2017
The Liver Meeting® 2017, the Annual Meeting of the American Association for the Study of Liver Disease
Washington, DC

Subcutaneous delivery of a RNA interference (RNAi) therapeutic candidate for alpha-1 antitrypsin deficiency (AATD)-related liver disease produces deep and prolonged knockdown of plasma AAT

  • Publication Number: LB-21
  • Session: Late-Breaking Poster Session
  • Session Date and Time: October 23, 2017 from 8:00 AM to 5:30 PM

·        Authors: Christine I. Wooddell, et al.

Oct 10, 2017 10:45 AM EDT
Chardan Gene Therapy Conference
Sep 25, 2017 9:10 AM EDT
2017 Cantor Fitzgerald Global Healthcare Conference
Sep 14, 2017 1:00 PM EDT
Arrowhead Analyst R&D Day
Aug 3, 2017 4:30 PM EDT
Arrowhead Fiscal 2017 Third Quarter Results
May 5, 2017 11:30 AM CDT
Arteriosclerosis, Thrombosis and Vascular Biology | Peripheral Vascular Disease (ATVB|PVD) 2017 Scientific Sessions

Location: Minneapolis, MN

Title: Factor 12 RNAi-based therapeutic as a prophylactic anti-thrombotic therapy

May 3, 2017 4:30 PM EDT
Arrowhead Fiscal 2017 Second Quarter Results
Apr 19 - Apr 23, 2017 12:00 AM EDT
The EASL International Liver Congress™ 2017
Amsterdam, The Netherlands

Prolonged RNA interference therapy with ARC-520 Injection in treatment naïve, HBeAg positive and negative patients with chronic HBV results in significant reductions of HBs antigen

  • Presentation Reference: PS-045
  • Session: Parallel session: Hepatitis B and D: Emerging treatment options
  • Date and Time: April 20, 2017 at 5:30 PM CET
  • Authors: Man-Fung Yuen, et al.

A phase 1 study to evaluate safety and tolerability of escalating single doses of the HBV RNA interference drug ARC-521 in a healthy volunteer population

  • Presentation Reference: THU-176
  • Session: Viral hepatitis: Hepatitis B and D - Clinical (therapy, new compounds, resistance)
  • Session Date and Time: April 20, 2017 from 8:00 AM to 6:00 PM CET
  • Authors: Edward Gane, et al.

Hepatic targeted RNA interference provides deep and prolonged knockdown of alpha-1 antitrypsin levels in ZZ patients

  • Presentation Reference: LBO-06
  • Session: Late Breaker session
  • Date and Time: April 22, 2017 at 5:15 PM CET
  • Authors: Alice Turner, et al.